The Impact of Hematologic Parameters on Histopathologic Features of Colorectal Cancer

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Kanavos P, Schurer W. The dynamics of colorectal cancer management in 17 countries. Eur J Health Econ. 2010;10(S1):115–129. doi:10.1007/s10198-009-0201-2
   Google Scholar
• Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2011. 2011. Available from: https://publications.gc.ca/collections/collection_2011/statcan/CS2-37-2011-eng.pdf. Accessed May, 2011.
   Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–545. doi:10.1016/S0140-6736(00)04046-0
   PubMed Web of Science ®Google Scholar
• Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12(10):584–596. doi:10.1038/nrclinonc.2015.105
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Toiyama Y, Yamamoto A, et al. Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg. 2019;270(6):e104–e105. doi:10.1097/SLA.0000000000003239
   PubMedGoogle Scholar
• Bozkurt Köseoğlu S, Dere Y. New predictive markers for benign endometrial lesions: platelet to lymphocyte and neutrophil to lymphocyte ratio. Ege Klin Derg. 2019;57(2):143–147.
   Google Scholar
• Xin-Ji Z, Yong-Gang L, Xiao-Jun S, Xiao-Wu C, Dong Z, Da-jian Z. The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: a meta-analysis. Int j Surg. 2015;21:84–91. doi:10.1016/j.ijsu.2015.07.681
   PubMed Web of Science ®Google Scholar
• Zhang X, Ran Y. Prognostic role of elevated platelet count in patients with lung cancer: a systematic review and meta-analysis. Int J Clin Exp Med. 2015;8(4):5379–5387.
   PubMed Web of Science ®Google Scholar
• Men H, Liang C, Yu M. Thrombocytosis as a prognostic factor in patients with renal cell carcinoma: a meta-analysis of literature. J Cancer Res Ther. 2015;11(1):67–72. doi:10.4103/0973-1482.150345
   PubMed Web of Science ®Google Scholar
• Yu M, Liu L, Zhang BL, et al. Pretreatment thrombocytosis as a prognostic factor in women with gynecologic malignancies: a meta-analysis. Asian Pac J Cancer Prev. 2012;13(12):6077–6081. doi:10.7314/APJCP.2012.13.12.6077
   PubMedGoogle Scholar
• Pine JK, Morris E, Hutchins GG, et al. Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. Br J Cancer. 2015;113(2):204–211. doi:10.1038/bjc.2015.87
   PubMed Web of Science ®Google Scholar
• Jankova L, Dent OF, Chan C, Chapuis P, Clarke SJ. Preoperative neutrophil/ lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer. BMC Cancer. 2013;13(1):442. doi:10.1186/1471-2407-13-442
   PubMedGoogle Scholar
• Shin JS, Suh KW, Oh SY. Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer. J Surg Oncol. 2015;112(6):654–657. doi:10.1002/jso.24061
   PubMed Web of Science ®Google Scholar
• Nagasaki T, Akiyoshi T, Fujimoto Y, et al. Prognostic impact of neutrophil-to-lymphocyte ratio in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy. Dig Surg. 2015;32(6):496–503. doi:10.1159/000441396
   PubMed Web of Science ®Google Scholar
• Palin RP, Devine AT, Hicks G, Burke D. Association of pretreatment neutrophil–lymphocyte ratio and outcome in emergency colorectal cancer care. Ann R Coll Surg Engl. 2018;100(4):308–315. doi:10.1308/rcsann.2017.0232
   PubMed Web of Science ®Google Scholar
• Emir S, Aydin M, Can G, et al. Comparison of colorectal neoplastic polyps and adenocarcinoma with regard to NLR and PLR. Eur Rev Med Pharmacol Sci. 2015;19(19):3613–3618.
   PubMed Web of Science ®Google Scholar
• Jia J, Zheng X, Chen Y, et al. Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer. Tumour Biol. 2015;36(12):9319–9325. doi:10.1007/s13277-015-3667-9
   PubMedGoogle Scholar
• Kwon HC, Kim SH, Oh SY, et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 2012;17(3):216–222. doi:10.3109/1354750X.2012.656705
   PubMed Web of Science ®Google Scholar
• Ozawa T, Ishihara S, Nishikawa T, et al. The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer. Int J Colorectal Dis. 2015;30(9):1165–1171. doi:10.1007/s00384-015-2276-9
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang HY, Li J, Shao XY, Zhang CX. The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(40):68837–68846. doi:10.18632/oncotarget.18575
   PubMedGoogle Scholar
• Nieswandt B, Hafner M, Echtenacher B, Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 1999;59(6):1295–1300.
   PubMed Web of Science ®Google Scholar
• Sasaki K, Kawai K, Tsuno NH, Sunami E, Kitayama J. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World J Surg. 2012;36(1):192–200. doi:10.1007/s00268-011-1329-7
   PubMed Web of Science ®Google Scholar
• Wan S, Lai Y, Myers RE, et al. Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients. J Gastrointest Cancer. 2013;44(3):293–304. doi:10.1007/s12029-013-9491-9
   PubMedGoogle Scholar